7
5-((1R*,4R*,5R*)-4-(butylammonio)-5-hydroxycyclopent-2-
en-1-yl)-1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-
4-olate 4be.
3287, 2918, 1640, 1544, 1314, 1255, 1204, 1143, 890, 676.
HRMS (ESI) calcd for C13H23N2O5 [M+H]+: 287.1601; found:
287.1603.
4.3. General procedure with NaH in 1,4-dioxane
From aziridine 2c (50 mg, 0.32 mmol, 1 equiv) and 1,3-
dimethylbarbituric acid 3e (61 mg, 0.39 mmol, 1.2 equiv). The
mixture was stirred at room temperature for 18 h. The crude
product was purified by flash chromatography on silica gel
eluting with dichloromethane/acetone (90/10); Acetone and
acetone/methanol (95/5); to afford 38 mg of 4be (42% yield) as a
In a Schlenk tube under an argon was prepared a solution of
Pd(OAc)2 (5 mol%,) and PPh3 (15 mol%) in 0.5 mL of distilled
1,4-dioxane. After 10 min of stirring, the aziridine (50 mg, 1
equiv) dissolved in 0.5 mL of distilled 1,4-dioxane was added,
and the mixture was stirred for another 10 minutes. A solution of
the nucleophile (1.2 equiv) deprotonated by sodium hydride (1.2
equiv) in 0.5 ml of 1,4-dioxane was added to the previous
mixture. The mixture was stirred at room temperature (25 °C)
overnight (18 h), and then dissolved with methanol. The solvent
was evaporated, and the crude product was purified by column
chromatographic to afford the desired product.
1
brown solid. m.p. 211-215 °C. H NMR (400 MHz, CDCl3) δ
10.43 (s, 1H), 9.23 (s, 1H), 5.95(dd, J = 5.7, 2.7 Hz, 1H), 5.68 (d,
J = 5.7 Hz, 1H), 4.15 (s, 1H), 3.99 (t, J = 2.4 Hz, 1H), 3.85 (d, J
= 2.1 Hz, 1H), 3.18 (s, 6H), 3.01 – 2.94 (m, 2H), 1.71 (q, J = 7.6
Hz, 2H), 1.43 (p, J = 7.2 Hz, 2H), 0.92 (t, J = 7.3 Hz, 3H).13C
NMR (75 MHz, CDCl3) δ 163.7, 152.7, 143.0, 121.1, 86.5, 79.5,
70.5, 51.5, 44.7, 28.9, 27.9, 19.9, 13.7. IR (cm-1): 3350, 2958,
2925, 2854, 1661, 1565, 1430, 1373, 1311, 1262, 1241, 1065,
1014, 963, 888, 796, 774, 732, 701, 582, 517, 485, 419. HRMS
(ESI) calcd for C15H24N3O4 [M+H]+: 310.1761; found: 310.1760.
Methyl 2-((1R*,4R*,5R*)-5-acetoxy-4-(butylamino)cyclopent-
2-en-1-yl)-3-oxobutanoate 4cb.
From aziridine 2c (50.5 mg, 0.26 mmol, 1 equiv) and methyl
acetoacetate (35.7 mg, 0.39 mmol, 1.2 equiv). The purification of
the crude product (NMR 74% using 1,4-nitroacetate as internal
standard) on silica gel eluting with cyclohexene/ethylacetate
(60/40; 30/70) did not allow to isolate pure the product 4cb
Ethyl 2-((1R*,4R*,5R*)-5-acetoxy-4-(butylamino)cyclopent-2-
en-1-yl)-2-nitroacetate 4cf.
From aziridine 2c (50 mg, 0.26 mmol, 1 equiv) and ethyl
nitroacetate 3f (40.9 mg, 0.31 mmol, 1.2 equiv). The mixture was
stirred at room temperature for 5 h. The crude product was
purified by flash chromatography on silica gel eluting with
cyclohexane/ethyl acetate (70/30) followed by crystallization
with cold diethyl ether and filtration to afford 20 mg of 4cf (24%
yield) as a brown solid. This product was difficult to isolate pure
due to the presence of triphenylphosphine oxide (71% NMR
without
triphenylphosphine
oxide
contamination.
1/1
1
diastereoisomeric mixture H NMR (400 MHz, CDCl3) δ 5.81
(dq, J = 4.9, 2.3 Hz, 1H, dia A+B), 5.71 (ddd, J = 5.5, 3.4, 1.7
Hz, 1H, dia A+B), 4.97 (t, J = 4 Hz, 1H, dia A), 4.89 (t, J = 4 Hz,
1H, dia B), 3.88 (s, 1H, dia A), 3.86 (s, 1H, dia B), 3.74 (s, 3H,
dia A), 3.72 (s, 3H, dia B), 3.30 – 3.27 (m, 1H, dia A+B), 2.66 –
2.60 (m, 1H, dia A+B), 2.25 (s, 3H, dia A), 2.24 (s, 3H, dia B),
2.06 (s, 3H, dia A), 2.05 (s, 3H, dia B), 1.49 – 1.24 (m, 4H, dia
A+B), 0.91 (t, J = 7.2 Hz, 3H, dia A+B). 13C NMR (75 MHz,
CDCl3) δ 202.0, 201.7, 171.2, 170.9, 169.0, 133.4, 133.0, 132.9,
132.0, 132.0, 131.5, 131.5, 82.3, 81.6, 70.2, 69.9, 62.5, 52.7,
52.5, 50.7, 50.3, 47.3, 47.2, 32.6, 32.6, 30.4, 29.9, 21.2, 20.5,
20.5, 14.1. IR (cm-1): 2954, 2925, 1742, 1676, 1536, 1424, 1377,
1323, 1241, 1197, 1166, 1140, 1107, 1037, 785, 767, 750.
HRMS (ESI) calcd for C16H26NO5 [M+H]+: 312.1805; found:
312.1802.
1
yield). m.p. 46-50 °C. 1/1 diastereoisomeric mixture H NMR
(400 MHz, CDCl3) δ 5.99 – 5.92 (m, 1H, dia A+B), 5.80 (d, J =
6.0 Hz, 1H, dia A), 5.76 (d, J = 6.1 Hz, 1H, dia B), 5.55 (d, J =
6.4 Hz, 1H, dia A+B), 5.12 – 5.07 (m, 1H, dia A), 5.05 – 5.01
(m, 1H, dia B), 4.35 – 4.24 (m, 2H, dia A+B), 3.79 (s, 1H, dia
A+B), 3.48 (s, 1H, dia A), 3.43 (s, 1H, dia B), 2.69 – 2.57 (m,
2H, dia A+B), 2.13 – 2.95 (m, 3H, dia A+B), 1.50 – 1.40 (m, 2H,
dia A+B), 1.39 – 1.27 (m, 5H, dia A+B), 0.91 (t, J = 7.2 Hz, 3H,
dia A+B). 13C NMR (101 MHz, CDCl3) δ 171.3, 171.1, 135.6,
135.3, 128.7, 128.2 89.8, 88.9, 80.6, 80.6, 69.9, 69.8, 63.3, 63.3,
52.9, 52.8, 47.4, 47.3, 32.6, 32.5, 21.1, 21.1, 20.5, 14.1, 13.9. IR
(cm-1): 3287, 2920, 2852, 1640, 1547, 1313, 1255, 1204, 697.
HRMS (ESI) calcd for C15H25N2O6 [M+H]+: 329.1707; obtained:
329.1706.
Methyl 2-((1R*,4R*,5R*)-4-(butylamino)-5-
hydroxycyclopent-2-en-1-yl)-3-oxobutanoate 4bb.
From aziridine 2b (50 mg, 0.32 mmol, 1 equiv) and acetoacetate
(45 mg, 0.39 mmol, 1.2 equiv). The crude product was purified
by flash chromatography on silica gel eluting with
dichloromethane/acetone (40/60) to afford 57 mg of 4bb (65%
Ethyl 2-((1R*,4R*,5R*)-4-(butylamino)-5-hydroxycyclopent-
2-en-1-yl)-2-nitroacetate 4bf.
1
yield) as a brown oil. 1/1 diastereoisomeric mixture H NMR
From aziridine 2b (50 mg, 0.32 mmol, 1 equiv) and ethyl
nitroacetate 3f (52 mg, 0.39 mmol, 1.2 equiv). The mixture was
stirred at room temperature for 1 h. The crude product was
purified by flash chromatography on silica gel eluting with
cyclohexane/ethyl acetate (1:1) and cyclohexane/ethyl
acetate/methanol (49.8/49.8/0.2; 49.5/49.5/1) to afford 30 mg of
4bf (32% yield) as a brown solid. m.p. 40-44 °C. 1/1
(400 MHz, CDCl3) δ 5.80 (dt, J = 6.2, 2.1 Hz, 1H, dia A+B), 5.66
(dt, J = 6.1, 1.8 Hz, 1H, dia A), 5.58 (dt, J = 6.1, 1.9 Hz, 1H, dia
B), 4.05 (t, J = 5.1 Hz, 1H, dia A), 3.95 (t, J = 5.2 Hz, 1H, dia B),
3.82 – 3.75 (m, 1H, dia A+B), 3.75 (s, 3H, dia A), 3.74 (s, 3H,
dia B), 3.68 (d, J = 8.9 Hz, 1H, dia A), 3.65 (d, J = 9.1 Hz, 1H,
dia B), 3.23 – 3.14 (m, 1H, dia A+B), 2.78 – 2.72 (m, 2H, dia
A+B), 2.27 (s, 3H, dia A+B), 1.62 – 1.47 (m, 2H, dia A+B), 1.43
– 1.27 (m, 2H, dia A+B), 0.91 (t, J = 7.4 Hz, 3H, dia A+B). 13C
NMR (101 MHz, CDCl3) δ 203.6, 202.7, 170.0, 169.3, 132.4,
131.6, 131.4, 130.7, 81.5 (2C), 71.4, 63.1, 62.4, 52.9, 52.8, 52.1,
51.8, 47.0, 31.7, 31.4, 30.3, 29.7, 20.5, 14.0, 14.0. IR (cm-1):
3348, 2956, 2930, 2872, 2126, 2006, 1978, 1713, 1647, 1577,
1529, 1460, 1424, 1375, 1327, 1253, 1212, 1185, 1163, 1106,
1055, 1029, 978, 939, 898, 860, 789, 765, 751, 683, 613, 533,
473, 392. HRMS (ESI) calcd for C14H24NO4 [M+H]+: 270.1700;
found: 270.1700.
1
diastereoisomeric mixture H NMR (300 MHz, CDCl3) δ 5.68
(d, J = 3.1 Hz, 1H, dia A), 5.58 (d, J = 3.0 Hz, 1H, dia B), 5.05
(d, J = 7.7 Hz, 1H, dia A), 4.96 (d, J = 8.7 Hz, 1H, dia B), 4.30
(p, J = 7.1 Hz, 2H, dia A+B), 4.02 (s, 1H, dia A+B), 3.80 – 3.73
(m, 1H, dia A+B), 3.00 – 2.93 (m, 2H, dia A+B), 2.78 – 2.66 (m,
1H, dia A+B), 2.47 – 2.34 (m, 1H, dia A+B), 1.52 (p, J = 7.1 Hz,
2H, dia A+B), 1.41 – 1.32 (m, 2H, dia A+B), 1.30 (td, J = 7.1,
2.5 Hz, 3H, dia A+B), 0.92 (t, J = 7.3 Hz, 3H, dia A+B). 13C
NMR (101 MHz, CDCl3) δ 200.8, 200.7, 163.3, 163.2, 147.7,
147.7, 114.1, 113.5, 91.4, 90.8, 77.3, 77.0, 76.7, 63.2, 63.2, 43.8,
37.6, 37.2, 37.1, 36.7, 30.9, 20.1, 13.9, 13.9, 13.7. IR (cm-1):